Paul Murray

Professor Paul Murray is a faculty member in the School of Medicine at the University of Limerick. He is affiliated with the Limerick Digital Cancer Research Centre and holds the rank of Professor. His research focuses on viral oncogenesis, particularly the role of Epstein-Barr Virus (EBV) in hematologic malignancies like Hodgkin's Lymphoma. His work integrates immunology, virology, and cancer biology to uncover mechanisms of viral-mediated tumorigenesis and immune evasion.

Recent research highlights include investigations into EBV-induced immunosuppression mechanisms, aflatoxin-B1 synergistic effects with EBV in B-cell infection, and NK cell dysfunction in pediatric cancers. He collaborates internationally on projects involving advanced imaging techniques for inflammatory bowel disease assessment and CRISPR-based therapeutic vulnerability identification in lymphomas. His work has been published in high-impact journals like Haematologica and Proceedings of the National Academy of Sciences.

Professor Murray's research network spans multiple countries, reflecting his collaborative approach to addressing complex biological systems in cancer and infectious diseases. His lab employs cutting-edge technologies including CRISPR screens, deep immune profiling, and multispectral imaging to advance translational research goals.